Reply: Optimal use of cholinergic drugs in Alzheimer's disease

Harald Hampel^{1

2

3

4}, Enrica Cavedo^{1

2

3

4}, Andrea Vergallo^{1

2

3

4}; Alzheimer Precision Medicine Initiative (APMI)

Affiliations

¹ AXA Research Fund and Sorbonne University Chair, Paris, France.
² Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Paris, France.
³ Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, Paris, France.
⁴ Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France.

Comment

Harald Hampel et al. Brain. 2018.

. 2018 Sep 1;141(9):e69.

doi: 10.1093/brain/awy205.

Harald Hampel^{1

2

3

4}, Enrica Cavedo^{1

2

3

4}, Andrea Vergallo^{1

2

3

4}; Alzheimer Precision Medicine Initiative (APMI)

¹ AXA Research Fund and Sorbonne University Chair, Paris, France.
² Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Paris, France.
³ Brain and Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Boulevard de l'hôpital, Paris, France.
⁴ Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France.

No abstract available

Comment on

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS. Hampel H, et al. Brain. 2018 Jul 1;141(7):1917-1933. doi: 10.1093/brain/awy132. Brain. 2018. PMID: 29850777 Free PMC article. Review.
Optimal use of cholinergic drugs in Alzheimer's disease.
Gauthier S, Herrmann N, Rosa-Neto P. Gauthier S, et al. Brain. 2018 Sep 1;141(9):e68. doi: 10.1093/brain/awy204. Brain. 2018. PMID: 30084978 No abstract available.